SLAYBACK PHARMA LLC FDA Approval ANDA 216815

ANDA 216815

SLAYBACK PHARMA LLC

FDA Drug Application

Application #216815

Application Sponsors

ANDA 216815SLAYBACK PHARMA LLC

Marketing Status

Prescription001

Application Products

001SOLUTION;INHALATIONEQ 0.015MG BASE/2ML0ARFORMOTEROL TARTRATEARFORMOTEROL TARTRATE

FDA Submissions

UNKNOWN; ORIG1AP2022-11-28STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAN

CDER Filings

SLAYBACK PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216815
            [companyName] => SLAYBACK PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ARFORMOTEROL TARTRATE","activeIngredients":"ARFORMOTEROL TARTRATE","strength":"EQ 0.015MG BASE\/2ML","dosageForm":"SOLUTION;INHALATION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ARFORMOTEROL TARTRATE","submission":"ARFORMOTEROL TARTRATE","actionType":"EQ 0.015MG BASE\/2ML","submissionClassification":"SOLUTION;INHALATION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.